CALR mutation burden in essential thrombocythemia and disease outcome.
In: Blood, Jg. 143 (2024-03-28), Heft 13, S. 1310-1314
academicJournal
Zugriff:
Abstract: Among 281 patients with essential thrombocythemia and calreticulin (CALR) mutation, we found a variant allele frequency of ≥60% to be associated with significantly shortened myelofibrosis-free survival, mostly apparent with CALR type-1 and CALR type-indeterminate mutations.
(© 2024 American Society of Hematology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.)
Titel: |
CALR mutation burden in essential thrombocythemia and disease outcome.
|
---|---|
Autor/in / Beteiligte Person: | Guglielmelli, P ; Szuber, N ; Gangat, N ; Capecchi, G ; Maccari, C ; Harnois, M ; Karrar, O ; Abdelmagid, M ; Balliu, M ; Nacca, E ; Atanasio, A ; Sestini, I ; Désilets, A ; Loscocco, GG ; Rotunno, G ; Busque, L ; Tefferi, A ; Vannucchi, AM |
Zeitschrift: | Blood, Jg. 143 (2024-03-28), Heft 13, S. 1310-1314 |
Veröffentlichung: | 2021- : [New York] : Elsevier ; <i>Original Publication</i>: New York, Grune & Stratton [etc.], 2024 |
Medientyp: | academicJournal |
ISSN: | 1528-0020 (electronic) |
DOI: | 10.1182/blood.2023023428 |
Schlagwort: |
|
Sonstiges: |
|